Bon Natural announces patent for postbiotic ingredient to regulate blood sugar

Bon Natural Life (BON) announced a patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term. Yongwei Hu, Chairman of the Company, said “Backed by a robust IP strategy, the Company is aggressively pursuing global patent protection. Over the next two years, we plan to lock down approvals across top markets, safeguarding our innovation while positioning ourselves for long-term dominance in the fast-growing metabolic health space. This strategic move not only shields the technology but also primes the business for scalable revenue growth and investor appeal.”